Log in to save to my catalogue

Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer - a first clin...

Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer - a first clin...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ccca38c495d34d30bceae848d305e18e

Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer - a first clinical approach

About this item

Full title

Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer - a first clinical approach

Publisher

England: BioMed Central Ltd

Journal title

Cancer imaging, 2021-02, Vol.21 (1), p.22-11, Article 22

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Expression of CXCR4, a chemokine (C-X-C motif) receptor that plays a central role in tumor growth and metastasis of circulating tumor cells, has been described in a variety of solid tumors. A high expression of CXCR4 has a prognostic significance with regard to overall and progression-free survival and offers a starting point for targeted therapies...

Alternative Titles

Full title

Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer - a first clinical approach

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ccca38c495d34d30bceae848d305e18e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ccca38c495d34d30bceae848d305e18e

Other Identifiers

ISSN

1470-7330,1740-5025

E-ISSN

1470-7330

DOI

10.1186/s40644-021-00391-w

How to access this item